查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1808846

分子製藥市場，按產品類型、按植物類型、按應用、按最終用戶、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Molecular Pharming Market, By Product Type, By Plant Type, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 389 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年分子製藥市場規模價值 17.8724 億美元，2025 年至 2032 年的複合年成長率為 8.5%。

分子製藥市場涉及利用基因改造植物生產疫苗、抗體、酵素和治療性蛋白質等藥物。這種創新的生物終端使用者製程透過插入編碼所需治療性蛋白質的特定基因，將植物轉化為生物工廠。分子製藥提供了一種經濟高效、可擴展且更安全的替代傳統細胞或微生物發酵方法的方法。它消除了人類病原體污染的風險，並可在健康危機期間快速部署。

菸草、玉米和水稻等作物因其生長迅速且易於基因操作而被廣泛使用。最終用戶因其可能徹底改變疫苗生產（尤其是在資源匱乏的地區）而備受關注。監管框架正在不斷發展，以解決安全性和有效性問題，有助於加速市場採用。隨著生技研發投資的增加，尤其是在傳染病、癌症和罕見疾病領域，對疫苗的需求也不斷增加。

分子藥市場-市場動態

在資源匱乏和流行病流行的情況下，對植物疫苗的需求不斷增加。

分子製藥市場的一個關鍵利基促進因素是植物疫苗需求的不斷成長，尤其是在資源匱乏的地區和疫情期間。傳統的疫苗生產方法通常依賴昂貴的基礎設施、冷鏈和漫長的生產週期，這使得它們在發展中地區難以獲得。分子製藥提供了一種解決方案，它能夠利用可在當地種植、資源極少的植物，實現快速、可擴展且經濟高效的生產。

在全球衛生緊急情況下，速度和可擴展性至關重要，這種方法尤其重要。植物性系統還能降低被動物或人類病原體污染的風險。此外，基因工程的進步提高了植物性疫苗研發的精準度和效率。生產口服或食用疫苗的能力也開啟了更容易分發的新型給藥方式。這種日益成長的興趣支持分子製藥成為實現全球公平醫療保健的策略工具。

分子製藥市場—關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年）全球市場預計年複合成長率約為 8.5%

根據產品類型細分，預計疫苗將在 2024 年佔據最大市場佔有率

根據植物類型細分，菸草是 2024 年的主要植物類型

根據應用細分，傳染病是 2024 年的主要應用

根據最終用戶細分，製藥公司是 2024 年的主要應用

從地區來看，北美是 2024 年最大的收入來源

分子藥物市場-細分分析：

全球分子藥物市場根據產品類型、植物類型、應用、最終用戶和地區進行細分。

根據產品類型，市場分為三類：疫苗、單株抗體、治療性蛋白、酵素和診斷性蛋白。依產品類型分類，分子製藥市場中最主要的市場區隔是疫苗。與傳統方法相比，透過分子製藥生產的疫苗因其快速、大規模且經濟高效的生產潛力而獲得了顯著的吸引力。植物性疫苗的研發速度更快，這在時間緊迫的疫情爆發和疫情期間至關重要。此外，由於植物不攜帶人類病原體，分子製藥可以生產更安全的疫苗，從而降低污染風險。

這個細分市場受惠於全球對平價疫苗日益成長的需求，尤其是在傳統疫苗生產基礎設施有限的發展中國家。基因工程的進步提高了疫苗在植物系統中的效力和穩定性。人們對流感、新冠肺炎和其他病毒感染等傳染病的日益關注，進一步推動了這個細分市場的成長。此外，監管機構正在逐步製定更清晰的植物源疫苗框架，以支持市場擴張。總體而言，疫苗仍然是領先的產品類型，推動了分子製藥市場的成長和創新。

根據植物類型，市場分為四類：菸草、玉米、水稻、馬鈴薯、藻類和其他。按植物類型分類，菸草在分子製藥市場中佔據主導地位。菸草植物因其生長速​​度快、生物量高且基因改造技術成熟而備受青睞。與糧食作物不同，菸草不供人類食用，這最大限度地減少了食品供應鏈中交叉污染的擔憂。菸草葉片為生產大量藥用蛋白（包括疫苗和單株抗體）提供了理想的平台。

此外，菸草能夠在溫室等受控環境中生長，從而實現持續且可擴展的生產。許多領先的生物技術公司利用菸草植物在衛生緊急情況下快速反應，包括生產傳染病抗體。圍繞菸草作為宿主植物的廣泛研究和基礎設施建設使其比其他植物類型更具競爭優勢。因此，菸草仍然是分子製藥植物類型的首選，推動了市場的顯著成長。

分子製藥市場—地理洞察

北美引領全球分子製藥市場，這得益於其先進的基礎設施、大量的研發投入以及有利的監管環境。尤其是美國，擁有眾多生技公司和研究機構，它們正在開拓植物性藥物的生產。該地區受益於強大的醫療保健體系、高昂的醫療支出以及優惠的報銷政策，從而促進了創新療法的推廣。產業領袖、學術機構和政府機構之間的合作加速了分子製藥技術的發展。

美國在分子製藥市場中處於領先地位，這得益於其強大的基礎設施、大量的研發投入以及良好的監管環境。美國先進的生物終端用戶領域擁有尖端的研究機構、完善的實驗室和完善的供應鏈網路，從而促進了分子製藥產品的高效開發和應用。政府措施發揮關鍵作用，提供財政激勵措施並促進產學合作，加速創新和商業化進程。

分子製藥市場-競爭格局：

分子製藥市場競爭激烈，主要由肯塔基生物處理公司 (Kentucky Bioprocessing)、Medicago、iBio、Ventria Bioscience 和 Protalix BioTherapeutics 等主要參與者主導。這些公司高度重視創新，以提高植物的蛋白質表現和生產效率。他們與學術機構和政府機構的策略夥伴關係十分常見，這有助於加速研發和監管批准。智慧財產權保護至關重要，許多參與者透過申請專利來保持競爭優勢。

為了確保一致的品質和可擴展性，對先進培養技術（包括受控環境農業和生物反應器）的投資正在增加。此外，企業透過瞄準疫苗和單株抗體等特定治療領域來脫穎而出。應對複雜的監管框架仍然是一項挑戰，同時也是進入市場的壁壘，這使得老牌企業得以鞏固其地位。總體而言，競爭推動了技術進步和分子製藥解決方案的更廣泛應用。

最新動態：

2024 年 10 月，Moolec Science 獲得美國監管部門批准，可生產富含鐵的牛肌紅蛋白的基因改造豌豆 (PEEA1)，為消費者提供植物性鐵來源。

2024 年 2 月，紐西蘭食品科技新創公司 Miruku 在 A 輪融資前籌集了 500 萬美元，用於擴大其旨在生產乳製品蛋白質和脂肪的分子農業平台。

目錄

第1章：分子製藥市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 分子製藥市場依產品類型分類
    • 分子製藥市場（按植物類型）摘要
    • 分子製藥市場片段（按應用）
    • 分子製藥市場片段（按最終用戶）
    • 分子製藥市場（按國家）摘要
    • 分子製藥市場（按地區）
  • 競爭洞察

第3章：分子製藥關鍵市場趨勢

  • 分子藥物市場促進因素
    • 市場促進因素的影響分析
  • 分子藥物市場限制
    • 市場限制的影響分析
  • 分子製藥市場機遇
  • 分子製藥市場未來趨勢

第4章：分子製藥業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：分子製藥市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：分子製藥市場格局

  • 2024年分子製藥市佔率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：分子藥市場－依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 疫苗
    • 單株抗體
    • 治療性蛋白質
    • 酵素
    • 診斷蛋白

第8章：分子製藥市場－依植物類型

  • 概述
    • 按工廠類型分類的細分市場佔有率分析
    • 菸草
    • 玉米
    • 米
    • 馬鈴薯
    • 藻類
    • 其他

第9章：分子製藥市場－依應用

  • 概述
    • 按應用細分市場佔有率分析
    • 傳染病
    • 癌症
    • 罕見疾病
    • 自體免疫疾病
    • 其他

第 10 章：分子製藥市場 - 按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 製藥公司
    • 生技公司
    • 研究機構
    • 合約研究組織（CRO）

第 11 章：分子藥物市場 - 按地理分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美分子製藥主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模及預測（按工廠類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模及預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲分子製藥主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模及預測（按工廠類型）
    • 歐洲市場規模和預測，按應用
    • 歐洲市場規模及預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區分子製藥主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依產品類型）
    • 亞太地區市場規模及預測（依工廠類型）
    • 亞太地區市場規模及預測（按應用）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲分子製藥主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（依產品類型）
    • 拉丁美洲市場規模及預測（依工廠類型）
    • 拉丁美洲市場規模及預測（按應用）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的分子製藥主要製造商
    • MEA 市場規模及預測（依國家/地區）
    • MEA 市場規模及預測（依產品類型）
    • MEA 市場規模及預測（依工廠類型）
    • MEA 市場規模及預測（按應用）
    • MEA 市場規模及預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 12 章：分子製藥產業主要供應商分析

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Kentucky Bioprocessing
    • Medicago
    • iBio
    • Ventria Bioscience
    • Protalix BioTherapeutics
    • PlantForm Corporation
    • Caliber Biotherapeutics
    • Fraunhofer USA
    • Icon Genetics
    • Greenovation Biotech
    • Dow AgroSciences
    • Zymeworks
    • Bayer CropScience
    • Cibus
    • PlantVax Inc.
    • AquaBounty Technologies
    • Phyton Biotech
    • Vaxess Technologies
    • Medicago Inc.
    • PlantForm Corp

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5495

Molecular Pharming Market size was valued at US$ 1,787.24 Million in 2024, expanding at a CAGR of 8.5% from 2025 to 2032.

The Molecular Pharming Market involves the use of genetically modified plants to produce pharmaceutical substances such as vaccines, antibodies, enzymes, and therapeutic proteins. This innovative bioEnd-user process transforms plants into biofactories by inserting specific genes that encode the desired therapeutic proteins. Molecular pharming offers a cost-effective, scalable, and safer alternative to traditional cell-based or microbial fermentation methods. It eliminates the risk of contamination from human pathogens and can be rapidly deployed during health crises.

Crops like tobacco, maize, and rice are commonly used due to their fast growth and ease of genetic manipulation. The End-user has gained attention for its potential to revolutionize vaccine production, especially in low-resource settings. Regulatory frameworks are evolving to address safety and efficacy concerns, helping accelerate market adoption. Demand is rising with increased investment in biotech R&D, especially for infectious diseases, cancer, and rare disorders.

Molecular Pharming Market- Market Dynamics

Rising demand for plant-based vaccines in low-resource and pandemic scenarios.

A key niche driver for the molecular pharming market is the rising demand for plant-based vaccines, especially in low-resource settings and during pandemic scenarios. Traditional vaccine production methods often rely on expensive infrastructure, cold chains, and long manufacturing timelines, making them less accessible in developing regions. Molecular pharming offers a solution by enabling rapid, scalable, and cost-effective production using plants, which can be grown locally with minimal resources.

This approach is particularly valuable during global health emergencies when speed and scalability are critical. Plant-based systems also reduce the risk of contamination with animal or human pathogens. Furthermore, advances in genetic engineering have enhanced the precision and efficiency of plant-based vaccine development. The ability to produce oral or edible vaccines also opens up new delivery methods that are easier to distribute. This growing interest supports molecular pharming as a strategic tool for equitable global healthcare.

Molecular Pharming Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2025-2032)

Based on product type segmentation, vaccines were predicted to show maximum market share in the year 2024

Based on Plant Type segmentation, tobacco was the leading Plant Type in 2024

Based on Application segmentation, Infectious Diseases were the leading Application in 2024

Based on End-User segmentation, Pharmaceutical Companies were the leading Application in 2024

Based on region, North America was the leading revenue generator in 2024

Molecular Pharming Market- Segmentation Analysis:

The Global Molecular Pharming Market is segmented on the basis of Product Type, Plant Type, Application, End-user, and Region.

The market is divided into three categories based on product type: Vaccines, Monoclonal Antibodies, Therapeutic Proteins, Enzymes, and Diagnostic Proteins. The most dominant segment in the molecular pharming market by product type is vaccines. Vaccines produced through molecular pharming have gained significant traction due to their potential for rapid, large-scale, and cost-effective production compared to traditional methods. Plant-based vaccines can be developed faster, which is crucial during outbreaks and pandemics where time is critical. Additionally, molecular pharming allows for the production of safer vaccines, as plants do not carry human pathogens, reducing contamination risks.

This segment benefits from growing global demand for affordable vaccines, especially in developing countries where traditional vaccine manufacturing infrastructure is limited. Advances in genetic engineering have improved vaccine efficacy and stability in plant systems. The increasing focus on infectious diseases, such as influenza, COVID-19, and other viral infections, further drives growth in this segment. Furthermore, regulatory agencies are gradually developing clearer frameworks for plant-derived vaccines, supporting market expansion. Overall, vaccines remain the leading product type, fueling the growth and innovation within the molecular pharming market.

The market is divided into four categories based on Plant Type: Tobacco, Maize (Corn), Rice, Potato, Algae, and Others. The tobacco segment is the most dominant in the molecular pharming market by plant type. Tobacco plants are preferred due to their fast growth rate, high biomass yield, and well-established genetic modification techniques. Unlike food crops, tobacco is not used for human consumption, which minimizes concerns about cross-contamination in the food supply chain. Its leaves provide an ideal platform for producing large quantities of pharmaceutical proteins, including vaccines and monoclonal antibodies.

Additionally, tobacco's ability to be grown in controlled environments such as greenhouses allows for consistent and scalable production. Many leading biotech companies have leveraged tobacco plants for rapid response during health emergencies, including producing antibodies for infectious diseases. The extensive research and infrastructure around tobacco as a host plant give it a competitive advantage over other plant types. As a result, tobacco continues to be the preferred choice for molecular pharming Plant Types, driving significant market growth.

Molecular Pharming Market- Geographical Insights

North America leads the global molecular pharming market, driven by its advanced infrastructure, substantial R&D investments, and a supportive regulatory environment. The United States, in particular, hosts numerous biotech firms and research institutions that are pioneering plant-based pharmaceutical production. This region benefits from a robust healthcare system, high healthcare expenditures, and favorable reimbursement policies, facilitating the adoption of innovative therapies. Collaborations between industry leaders, academic institutions, and government agencies have accelerated the development of molecular pharming technologies.

The United States stands at the forefront of the molecular pharming market, driven by a confluence of robust infrastructure, substantial R&D investments, and a supportive regulatory environment. The nation's advanced bioEnd-user sector is characterized by cutting-edge research institutions, well-established laboratories, and a comprehensive supply chain network, facilitating the efficient development and Application of molecular pharming products. Government initiatives play a pivotal role, offering financial incentives and fostering collaborations between industry, academia, and research institutions, thereby accelerating innovation and commercialization.

Molecular Pharming Market- Competitive Landscape:

The molecular pharming market features a competitive landscape dominated by key players such as Kentucky Bioprocessing, Medicago, iBio, Ventria Bioscience, and Protalix BioTherapeutics. These companies focus heavily on innovation to improve protein expression and production efficiency in plants. Strategic partnerships with academic institutions and government bodies are common, helping to accelerate R&D and regulatory approvals. Intellectual property protection is a critical factor, with many players securing patents to maintain their competitive edge.

Investments in advanced cultivation technologies, including controlled environment agriculture and bioreactors, are increasing to ensure consistent quality and scalability. Additionally, companies differentiate themselves by targeting specific therapeutic areas like vaccines and monoclonal antibodies. Navigating complex regulatory frameworks remains a challenge but also a barrier to entry, allowing established players to strengthen their positions. Overall, the competition drives technological progress and wider adoption of molecular pharming solutions.

Recent Developments:

In October 2024, Moolec Science obtained U.S. regulatory approval for genetically engineered peas (PEEA1) that produce iron-rich bovine myoglobin, offering a plant-based source of iron for consumers.

In February 2024, New Zealand-based food tech startup Miruku raised $5 million in a pre-Series A financing round to expand its molecular farming platform aimed at producing dairy proteins and fats.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MOLECULAR PHARMING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Kentucky Bioprocessing
  • Medicago
  • iBio
  • Ventria Bioscience
  • Protalix BioTherapeutics
  • PlantForm Corporation
  • Caliber Biotherapeutics
  • Fraunhofer USA
  • Icon Genetics
  • Greenovation Biotech
  • Dow AgroSciences
  • Zymeworks
  • Bayer CropScience
  • Cibus
  • PlantVax Inc.
  • AquaBounty Technologies
  • Phyton Biotech
  • Vaxess Technologies
  • Medicago Inc.
  • PlantForm Corp.

GLOBAL MOLECULAR PHARMING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Vaccines
  • Monoclonal Antibodies
  • Therapeutic Proteins
  • Enzymes
  • Diagnostic Proteins

GLOBAL MOLECULAR PHARMING MARKET, BY PLANT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Tobacco
  • Maize (Corn)
  • Rice
  • Potato
  • Algae
  • Others

GLOBAL MOLECULAR PHARMING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Infectious Diseases
  • Cancer
  • Rare Diseases
  • Autoimmune Disorders
  • Others

GLOBAL MOLECULAR PHARMING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Research Institutes
  • Contract Research Organizations (CROs)

GLOBAL MOLECULAR PHARMING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Molecular Pharming Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Molecular Pharming Market Snippet by Product Type
    • 2.1.2. Molecular Pharming Market Snippet by Plant Type
    • 2.1.3. Molecular Pharming Market Snippet by Application
    • 2.1.4. Molecular Pharming Market Snippet by End-user
    • 2.1.5. Molecular Pharming Market Snippet by Country
    • 2.1.6. Molecular Pharming Market Snippet by Region
  • 2.2. Competitive Insights

3. Molecular Pharming Key Market Trends

  • 3.1. Molecular Pharming Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Molecular Pharming Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Molecular Pharming Market Opportunities
  • 3.4. Molecular Pharming Market Future Trends

4. Molecular Pharming Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Molecular Pharming Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Molecular Pharming Market Landscape

  • 6.1. Molecular Pharming Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Molecular Pharming Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Vaccines
    • 7.1.3. Monoclonal Antibodies
    • 7.1.4. Therapeutic Proteins
    • 7.1.5. Enzymes
    • 7.1.6. Diagnostic Proteins

8. Molecular Pharming Market - By Plant Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Plant Type, 2024 & 2032 (%)
    • 8.1.2. Tobacco
    • 8.1.3. Maize (Corn)
    • 8.1.4. Rice
    • 8.1.5. Potato
    • 8.1.6. Algae
    • 8.1.7. Others

9. Molecular Pharming Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Infectious Diseases
    • 9.1.3. Cancer
    • 9.1.4. Rare Diseases
    • 9.1.5. Autoimmune Disorders
    • 9.1.6. Others

10. Molecular Pharming Market - By End-user

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Biotechnology Companies
    • 10.1.4. Research Institutes
    • 10.1.5. Contract Research Organizations (CROs)

11. Molecular Pharming Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Molecular Pharming Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Molecular Pharming Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Molecular Pharming Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Molecular Pharming Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Molecular Pharming Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Molecular Pharming Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Kentucky Bioprocessing
    • 12.2.2. Medicago
    • 12.2.3. iBio
    • 12.2.4. Ventria Bioscience
    • 12.2.5. Protalix BioTherapeutics
    • 12.2.6. PlantForm Corporation
    • 12.2.7. Caliber Biotherapeutics
    • 12.2.8. Fraunhofer USA
    • 12.2.9. Icon Genetics
    • 12.2.10. Greenovation Biotech
    • 12.2.11. Dow AgroSciences
    • 12.2.12. Zymeworks
    • 12.2.13. Bayer CropScience
    • 12.2.14. Cibus
    • 12.2.15. PlantVax Inc.
    • 12.2.16. AquaBounty Technologies
    • 12.2.17. Phyton Biotech
    • 12.2.18. Vaxess Technologies
    • 12.2.19. Medicago Inc.
    • 12.2.20. PlantForm Corp

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us